CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
- 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
- 4 Grant or award President acquired 83,162 shares (grant or award)
- 4 Grant or award See Remarks acquired 83,162 shares (grant or award)
- 4 Grant or award See Remarks acquired 320,112 shares (grant or award)
- 10-K Report Annual Report
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 3,739 shares (grant or award)
- 4 Grant or award Director acquired 5,509 shares (grant or award)
- 8-K Event Results of operations · Regulation FD disclosure
Page 3 of 7 · 134 filings